🇺🇸 FDA
Patent

US 12370192

Azole-fused pyridazin-3(2H)-one derivatives

granted A61KA61K31/5025

Quick answer

US patent 12370192 (Azole-fused pyridazin-3(2H)-one derivatives) held by Takeda Pharmaceutical Company Limited expires Mon Jul 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Jul 29 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
28
CPC classes
A61K, A61K31/5025